[ABO-RH1 grouping and red blood cell antibody screening: error analysis in the French external quality assessment in 2006].
Further to a survey set up in 2006 over 2600 laboratories by the French agency for health product safety (AFSSAPS), seven ABO grouping errors and 53 negative answers to red blood cell antibody screening with a serum containing anti-RH1 antibody, have been found. A questionnaire sent to the involved laboratories revealed non-analytical errors already met in previous cases. Besides, the analytical stage has also induced red blood cell antibody screening errors due to a wrong serum collection by the automat. Here are displayed the analysis of the questionnaire results and proposed corrections.
Guyard
A
A
Agence française de sécurité sanitaire des produits de santé (Afssaps), 143-147, boulevard Anatole-France, 93285 Saint-Denis cedex, France. anne.guyard@afssaps.sante.fr
Albarède
S
S
Mannessier
L
L
Rouger
P
P
Dumont
G
G
D000017:ABO Blood-Group System / Q000276:immunology*; D003258:Consumer Behavior; D017707:Erythrocyte Transfusion / Q000592:standards*; D004912:Erythrocytes / Q000276:immunology*; D005602:France; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D012204:Rh-Hr Blood-Group System / Q000276:immunology*; D011795:Surveys and Questionnaires
D000017:ABO Blood-Group System; D006454:Hemoglobins; D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System